Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Risankizumab for Inflammatory Bowel Disease
Recruiting3 awardsPhase 4
Chapel Hill, North Carolina
"This trial is studying the levels of risankizumab in the breast milk of lactating women with Inflammatory Bowel Disease (IBD). Risankizumab is a drug used to
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.